Genetic, pathogenic, and antigenic characterization of GX-1, a novel infectious bronchitis virus genotype identified in South Korea

对韩国发现的一种新型传染性支气管炎病毒基因型GX-1进行遗传、致病和抗原特征分析

阅读:2
作者:Seung-Ji Kim,Ho-Won Kim,Sun-Min Ahn,Seung-Eun Son,Jin-Ha Song,Yong-Baek Kim,Hyuk-Joon Kwon,Kang-Seuk Choi

Abstract

Infectious bronchitis virus (IBV), a highly contagious avian coronavirus, remains a major threat to global poultry production due to its rapid genetic evolution and frequent antigenic shifts. During a nationwide surveillance program in South Korea (2024-2025), we identified a previously unrecognized IBV lineage within dead birds in commercial chicken flocks. The Spike 1 (S1) gene of the IBVs belonging to this lineage exhibited less than 75 % nucleotide identity with those of any previously reported IBV genotypes. Phylogenetic analysis demonstrated that this virus forms a distinct monophyletic clade, with no evidence of recombination detected within the S1 gene. On the basis of these genetic and phylogenetic characteristics, we propose that this virus represents the first lineage of a novel tenth IBV genotype, herein designated GX-1. Complete genome analysis further revealed a high degree of similarity to the recent East Asian GI-19 lineage, except within the Spike (S) gene, suggesting recombination on an East Asian GI-19 genomic backbone. Experimental infection of specific-pathogen-free (SPF) chickens with the proposed GX-1 IBV resulted in milder clinical manifestations, lower lesion severity, and lower mortality compared with infection with the GI-19 IBV isolate. Notably, GX-1 did not induce severe nephritis or renal lesions, indicating a loss of nephropathogenicity, a hallmark of GI-19 IBV infections. Although the virus was detected in respiratory, gastrointestinal, and internal organ tissues, its load and persistence were consistently lower than those of GI-19. Antigenic analysis further revealed limited cross-reactivity between GX-1 and GI-19 IBVs, suggesting distinct serotype characteristics. These results indicate that the proposed GX-1 IBV is a genetically distinct genotype with reduced pathogenicity, altered tissue tropism, and distinct antigenic properties. The emergence of this strain highlights the need for ongoing genomic surveillance and genotype-matched vaccines to manage the evolving IBV landscape.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。